|
Your healthcare provider has determined that REQUIP may be the right treatment for you. Studies have shown REQUIP to be effective in the management of the early stages of Parkinson's disease as well as in advanced stages as additional therapy to L-dopa. |
| People with Parkinson's disease produce less dopamine than their bodies need to maintain normal movement. REQUIP belongs to a class of drugs known as dopamine agonists, which stimulate the same brain centers as dopamine does, helping to improve the symptoms of Parkinson's disease. | |
Dosing Information for REQUIP
|
|
Work with Your Healthcare Provider
|
|
*The sample kit for REQUIP provides dosing up to 9 mg/day. After week 8, if necessary, the total daily dose may be increased up to a maximum of 24 mg.


